Grosso G, Tognetti R, Domenech O, Della Pina A, Marchesotti F, Patata V
J Vet Intern Med. 2025; 39(1):e17241.
PMID: 39846767
PMC: 11755767.
DOI: 10.1111/jvim.17241.
Katz M, Ohad D, Putter P, Shtraizent N, Shahar E, Tal S
Front Vet Sci. 2024; 11:1415030.
PMID: 39376911
PMC: 11457017.
DOI: 10.3389/fvets.2024.1415030.
Yuchi Y, Suzuki R, Ishida N, Satomi S, Saito T, Teshima T
Biology (Basel). 2024; 13(5).
PMID: 38785793
PMC: 11118215.
DOI: 10.3390/biology13050311.
Duler L, Visser L, Nguyen N, Johnson L, Stern J, Li R
J Vet Intern Med. 2024; 38(4):2052-2063.
PMID: 38773707
PMC: 11256165.
DOI: 10.1111/jvim.17067.
Corda A, Corda F, Pentcheva P, Puci M, Mollica A, Gomez Ochoa P
J Vet Intern Med. 2024; 38(4):2064-2075.
PMID: 38715386
PMC: 11256189.
DOI: 10.1111/jvim.17097.
Indicators for pulmonary hypertension in dogs with degenerative mitral valve disease.
Chalermpromma P, Surachetpong S
Vet World. 2024; 16(12):2515-2520.
PMID: 38328363
PMC: 10844776.
DOI: 10.14202/vetworld.2023.2515-2520.
Proteomic analysis of pulmonary arteries and lung tissues from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease.
Sakarin S, Rungsipipat A, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, Charoenlappanit S
PLoS One. 2024; 19(1):e0296068.
PMID: 38181036
PMC: 10769092.
DOI: 10.1371/journal.pone.0296068.
Usefulness of Tissue Doppler Imaging for the Evaluation of Pulmonary Hypertension in Canine Heartworm Disease.
Matos J, Garcia-Rodriguez S, Costa-Rodriguez N, Caro-Vadillo A, Carreton E, Montoya-Alonso J
Animals (Basel). 2023; 13(23).
PMID: 38066998
PMC: 10705064.
DOI: 10.3390/ani13233647.
Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension.
Yuchi Y, Suzuki R, Yasumura Y, Saito T, Teshima T, Matsumoto H
J Vet Intern Med. 2023; 37(3):856-865.
PMID: 36994902
PMC: 10229321.
DOI: 10.1111/jvim.16686.
Perivascular inflammatory cells and their association with pulmonary arterial remodelling in dogs with pulmonary hypertension due to myxomatous mitral valve disease.
Sakarin S, Rungsipipat A, Surachetpong S
Vet Res Commun. 2023; 47(3):1505-1521.
PMID: 36976445
DOI: 10.1007/s11259-023-10106-0.
Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C.
Udomkiattikul J, Kirdratanasak N, Siritianwanitchakul P, Worapunyaanun W, Surachetpong S
Int J Vet Sci Med. 2022; 10(1):25-32.
PMID: 35573138
PMC: 9068001.
DOI: 10.1080/23144599.2022.2067630.
Investigation of Beraprost Sodium on Cardiac Function and Hemodynamics in Canine Models of Chronic Pulmonary Hypertension.
Suzuki R, Yuchi Y, Saito T, Teshima T, Matsumoto H, Koyama H
Front Vet Sci. 2022; 9:876178.
PMID: 35498754
PMC: 9048895.
DOI: 10.3389/fvets.2022.876178.
Management of Chronic Congestive Heart Failure Caused by Myxomatous Mitral Valve Disease in Dogs: A Narrative Review from 1970 to 2020.
Bagardi M, Zamboni V, Locatelli C, Galizzi A, Ghilardi S, Brambilla P
Animals (Basel). 2022; 12(2).
PMID: 35049831
PMC: 8773235.
DOI: 10.3390/ani12020209.
Pulmonary Vascular Resistance Estimated by Echocardiography in Dogs With Myxomatous Mitral Valve Disease and Pulmonary Hypertension Probability.
Suzuki R, Yuchi Y, Kanno H, Saito T, Teshima T, Matsumoto H
Front Vet Sci. 2021; 8:771726.
PMID: 34765671
PMC: 8576378.
DOI: 10.3389/fvets.2021.771726.
Right ventricular systolic and diastolic function assessed by two-dimensional speckle tracking echocardiography in dogs with myxomatous mitral valve disease.
Yuchi Y, Suzuki R, Teshima T, Matsumoto H, Koyama H
J Vet Med Sci. 2021; 83(12):1918-1927.
PMID: 34732606
PMC: 8762426.
DOI: 10.1292/jvms.21-0195.
Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS.
Riengvirodkij N, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, Charoenlappanich S, Sakcamduang W
PLoS One. 2021; 16(8):e0255611.
PMID: 34383793
PMC: 8360550.
DOI: 10.1371/journal.pone.0255611.
Non-invasive Assessment of Pulmonary Artery Wave Reflection in Dogs With Suspected Pulmonary Hypertension.
Yoshida T, Matsuura K, Seijirow G, Uemura A, Yilmaz Z, Tanaka R
Front Vet Sci. 2021; 8:659194.
PMID: 34307519
PMC: 8298900.
DOI: 10.3389/fvets.2021.659194.
Assessment of Platelet and Plasma Serotonin in Canine Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease.
Tangmahakul N, Makoom P, Surachetpong S
Front Vet Sci. 2021; 8:695492.
PMID: 34212025
PMC: 8239174.
DOI: 10.3389/fvets.2021.695492.
Clinical and Echocardiographic Findings in an Aged Population of Cavalier King Charles Spaniels.
Prieto Ramos J, Corda A, Swift S, Saderi L, de la Fuente Oliver G, Corcoran B
Animals (Basel). 2021; 11(4).
PMID: 33800666
PMC: 8065390.
DOI: 10.3390/ani11040949.
The Expression of Proteins Related to Serotonin Pathway in Pulmonary Arteries of Dogs Affected With Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease.
Sakarin S, Surachetpong S, Rungsipipat A
Front Vet Sci. 2021; 7:612130.
PMID: 33426031
PMC: 7793840.
DOI: 10.3389/fvets.2020.612130.
